{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T16:01:52Z","timestamp":1772121712241,"version":"3.50.1"},"reference-count":52,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,15]],"date-time":"2022-11-15T00:00:00Z","timestamp":1668470400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000185","name":"Defense Advanced Research Projects Agency","doi-asserted-by":"publisher","award":["D16AP00114"],"award-info":[{"award-number":["D16AP00114"]}],"id":[{"id":"10.13039\/100000185","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.vaccine.2022.11.028","type":"journal-article","created":{"date-parts":[[2022,11,21]],"date-time":"2022-11-21T07:46:08Z","timestamp":1669016768000},"page":"182-192","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Expected endpoints from future chikungunya vaccine trial sites informed by serological data and modeling"],"prefix":"10.1016","volume":"41","author":[{"given":"Quan Minh","family":"Tran","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Soda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amir","family":"Siraj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sean","family":"Moore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hannah","family":"Clapham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Alex Perkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2022.11.028_b0005","doi-asserted-by":"crossref","first-page":"30234","DOI":"10.2807\/1560-7917.ES.2016.21.20.30234","article-title":"Global distribution and environmental suitability for chikungunya virus, 1952 to 2015","volume":"21","author":"Nsoesie","year":"2016","journal-title":"Eurosurveillance"},{"key":"10.1016\/j.vaccine.2022.11.028_b0010","doi-asserted-by":"crossref","unstructured":"Lumsden WH. An epidemic of virus disease in Southern Province, Tanganyika Territory, in 1952-53. II. General description and epidemiology. Trans R Soc Trop Med Hyg 1955; 49: 33\u201357. https:\/\/doi.org\/10.1016\/0035-9203(55)90081-x.","DOI":"10.1016\/0035-9203(55)90081-X"},{"key":"10.1016\/j.vaccine.2022.11.028_b0015","first-page":"660","article-title":"Haemorrhagic fever in Calcutta area","volume":"52","author":"Aikat","year":"1964","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.vaccine.2022.11.028_b0020","first-page":"20759","article-title":"Chikungunya outbreak in the Caribbean region, December 2013 to March 2014, and the significance for Europe","volume":"19","author":"Van Bortel","year":"2014","journal-title":"Euro Surveill Bull Eur Sur Mal Transm Eur Commun Dis Bull"},{"key":"10.1016\/j.vaccine.2022.11.028_b0025","doi-asserted-by":"crossref","first-page":"S441","DOI":"10.1093\/infdis\/jiw390","article-title":"Epidemiology of Chikungunya in the Americas","volume":"214","author":"Yactayo","year":"2016","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2022.11.028_b0030","doi-asserted-by":"crossref","first-page":"508","DOI":"10.4269\/ajtmh.2010.09-0322","article-title":"Chikungunya Virus in North-Eastern Italy: A Seroprevalence Survey","volume":"82","author":"Moro","year":"2010","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2022.11.028_b0035","first-page":"3","article-title":"Post-Epidemic Chikungunya Disease on Reunion Island: Course of Rheumatic Manifestations and Associated Factors over a 15-Month Period","author":"Sissoko","year":"2009","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2022.11.028_b0040","first-page":"313","article-title":"Chikungunya virus infection. A retrospective study of 107 cases","volume":"63","author":"Brighton","year":"1983","journal-title":"South Afr Med J Suid-Afr Tydskr Vir Geneeskd"},{"key":"10.1016\/j.vaccine.2022.11.028_b0045","unstructured":"Ed F, Jg M. Rheumatoid arthritic syndrome after chikungunya fever. South Afr Med J Suid-Afr Tydskr Vir Geneeskd 1979; 56. https:\/\/pubmed.ncbi.nlm.nih.gov\/494034\/ (accessed September 15, 2020)."},{"key":"10.1016\/j.vaccine.2022.11.028_b0050","doi-asserted-by":"crossref","unstructured":"Sp M, P V, R U, Ap S, Ss S, Sk R, et al. Clinical progression of chikungunya fever during acute and chronic arthritic stages and the changes in joint morphology as revealed by imaging. Trans R Soc Trop Med Hyg 2010;104. https:\/\/doi.org\/10.1016\/j.trstmh.2010.01.011.","DOI":"10.1016\/j.trstmh.2010.01.011"},{"key":"10.1016\/j.vaccine.2022.11.028_b0055","doi-asserted-by":"crossref","first-page":"e7800","DOI":"10.1371\/journal.pone.0007800","article-title":"Impact of Chikungunya virus infection on health status and quality of life: a retrospective cohort study","volume":"4","author":"Soumahoro","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2022.11.028_b0060","doi-asserted-by":"crossref","first-page":"e0004551","DOI":"10.1371\/journal.pntd.0004551","article-title":"Is Dengue Vector Control Deficient in Effectiveness or Evidence?: Systematic Review and Meta-analysis","volume":"10","author":"Bowman","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2022.11.028_b0065","doi-asserted-by":"crossref","first-page":"20190973","DOI":"10.1098\/rspb.2019.0973","article-title":"Reflections from an old Queenslander: can rear and release strategies be the next great era of vector control?","volume":"286","author":"Ritchie","year":"2019","journal-title":"Proc R Soc B Biol Sci"},{"key":"10.1016\/j.vaccine.2022.11.028_b0070","doi-asserted-by":"crossref","first-page":"e1007743","DOI":"10.1371\/journal.pcbi.1007743","article-title":"Optimizing the deployment of ultra-low volume and targeted indoor residual spraying for dengue outbreak response","volume":"16","author":"Cavany","year":"2020","journal-title":"PLOS Comput Biol"},{"key":"10.1016\/j.vaccine.2022.11.028_b0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pntd.0006919","article-title":"Chikungunya as a paradigm for emerging viral diseases: Evaluating disease impact and hurdles to vaccine development","volume":"13","author":"Rezza","year":"2019","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2022.11.028_b0080","unstructured":"Valneva Successfully Completes Pivotal Phase 3 Trial of Single-Shot Chikungunya Vaccine Candidate \u2013 Valneva n.d. https:\/\/valneva.com\/press-release\/valneva-successfully-completes-pivotal-phase-3-trial-of-single-shot-chikungunya-vaccine-candidate\/ (accessed March 10, 2022)."},{"key":"10.1016\/j.vaccine.2022.11.028_b0085","unstructured":"Emergent BioSolutions. A Phase 3 Safety, Immunogenicity, and Lot-Consistency Trial of the VLP-Based Chikungunya Vaccine PXVX0317 in Healthy Adults and Adolescents. clinicaltrials.gov; 2021."},{"key":"10.1016\/j.vaccine.2022.11.028_b0090","unstructured":"World Health Organization. Emergency Use Listing Procedure. 2020."},{"key":"10.1016\/j.vaccine.2022.11.028_b0095","unstructured":"World Health Organization. WHO Operational Tool for efficient and effective lot release of SARS-CoV-2 (Covid-19) vaccines 2021. https:\/\/extranet.who.int\/pqweb\/sites\/default\/files\/documents\/WHO_OperationalTool_EfficientLotRelease_v20Jan2021.pdf (accessed March 9, 2022)."},{"key":"10.1016\/j.vaccine.2022.11.028_b0100","first-page":"11","article-title":"Considerations for the design of vaccine efficacy trials during public health emergencies","author":"Dean","year":"2019","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.vaccine.2022.11.028_b0105","doi-asserted-by":"crossref","first-page":"e0010069","DOI":"10.1371\/journal.pntd.0010069","article-title":"The global epidemiology of chikungunya from 1999 to 2020: A systematic literature review to inform the development and introduction of vaccines","volume":"16","author":"Bettis","year":"2022","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2022.11.028_b0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12916-017-0985-3","article-title":"Simulations for designing and interpreting intervention trials in infectious diseases","volume":"15","author":"Halloran","year":"2017","journal-title":"BMC Med"},{"key":"10.1016\/j.vaccine.2022.11.028_b0115","article-title":"Preliminary results of models to predict areas in the Americas with increased likelihood of Zika virus transmission in 2017","author":"Collaboration","year":"2017","journal-title":"BioRxiv"},{"key":"10.1016\/j.vaccine.2022.11.028_b0120","doi-asserted-by":"crossref","unstructured":"Madewell ZJ, Piontti APY, Zhang Q, Burton N, Yang Y, Longini IM, et al. Using simulated infectious disease outbreaks to guide the design of individually randomized vaccine trials. MedRxiv 2021:2021.01.29.21250703. https:\/\/doi.org\/10.1101\/2021.01.29.21250703.","DOI":"10.1101\/2021.01.29.21250703"},{"key":"10.1016\/j.vaccine.2022.11.028_b0125","doi-asserted-by":"crossref","first-page":"e0005470","DOI":"10.1371\/journal.pntd.0005470","article-title":"Using simulation to aid trial design: Ring-vaccination trials","volume":"11","author":"Hitchings","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2022.11.028_b0130","doi-asserted-by":"crossref","first-page":"e0009208","DOI":"10.1371\/journal.pntd.0009208","article-title":"Co-circulation and misdiagnosis led to underestimation of the 2015\u20132017 Zika epidemic in the Americas","volume":"15","author":"Oidtman","year":"2021","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2022.11.028_b0135","doi-asserted-by":"crossref","first-page":"e0006246","DOI":"10.1371\/journal.pntd.0006246","article-title":"Evidence of previous but not current transmission of chikungunya virus in southern and central Vietnam: Results from a systematic review and a seroprevalence study in four locations","volume":"12","author":"Quan","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2022.11.028_b0140","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1093\/infdis\/jiv470","article-title":"Reconstruction of 60 Years of Chikungunya Epidemiology in the Philippines Demonstrates Episodic and Focal Transmission","volume":"213","author":"Salje","year":"2016","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2022.11.028_b0145","unstructured":"R Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: 2020."},{"key":"10.1016\/j.vaccine.2022.11.028_b0150","unstructured":"Github link. https:\/\/github.com\/tranquanc123\/CHIKV_endpoint_est.git."},{"key":"10.1016\/j.vaccine.2022.11.028_b0155","unstructured":"Affairs UND of E and S. World Population Prospects: Data Booklet - 2015 Revision. United Nations; 2016. https:\/\/doi.org\/10.18356\/a3ba30cd57-en."},{"key":"10.1016\/j.vaccine.2022.11.028_b0160","doi-asserted-by":"crossref","unstructured":"Cauchemez S, Hoze N, Cousien A, Nikolay B, ten bosch Q. How Modelling Can Enhance the Analysis of Imperfect Epidemic Data. Trends Parasitol 2019;35:369\u201379. https:\/\/doi.org\/10.1016\/j.pt.2019.01.009.","DOI":"10.1016\/j.pt.2019.01.009"},{"key":"10.1016\/j.vaccine.2022.11.028_b0165","unstructured":"Florian Hartig, Francesco Minunno, Stefan Paul. BayesianTools: General-Purpose MCMC and SMC Samplers and Tools for Bayesian Statistics. 2019."},{"key":"10.1016\/j.vaccine.2022.11.028_b0170","doi-asserted-by":"crossref","DOI":"10.1371\/currents.outbreaks.a4c7b6ac10e0420b1788c9767946d1fc","article-title":"Estimating Drivers of Autochthonous Transmission of Chikungunya Virus in its Invasion of the Americas","author":"Perkins","year":"2015","journal-title":"PLOS Curr Outbreaks"},{"key":"10.1016\/j.vaccine.2022.11.028_b0175","unstructured":"Martyn Plummer, Nicky Best, Kate Cowles, Karen Vines. CODA: Convergence Diagnosis and Output Analysis for MCMC. 2006."},{"key":"10.1016\/j.vaccine.2022.11.028_b0180","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/anzs.12263","article-title":"R package rjmcmc : reversible jump MCMC using post-processing","volume":"61","author":"Gelling","year":"2019","journal-title":"Aust N Z J Stat"},{"key":"10.1016\/j.vaccine.2022.11.028_b0185","unstructured":"World Health Organization. WHO consultation on Chikungunya vaccine evaluation. Geneva, Switzerland: 2018."},{"key":"10.1016\/j.vaccine.2022.11.028_b0190","unstructured":"Chikungunya - Chapter 4 - 2020 Yellow Book | Travelers\u2019 Health | CDC n.d. https:\/\/wwwnc.cdc.gov\/travel\/yellowbook\/2020\/travel-related-infectious-diseases\/chikungunya (accessed September 15, 2020)."},{"key":"10.1016\/j.vaccine.2022.11.028_b0195","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1172\/JCI84417","article-title":"Chikungunya virus: epidemiology, replication, disease mechanisms, and prospective intervention strategies","volume":"127","author":"Silva","year":"2017","journal-title":"J Clin Invest"},{"key":"10.1016\/j.vaccine.2022.11.028_b0200","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1086\/605496","article-title":"Chikungunya Fever: An Epidemiological Review of a Re-Emerging Infectious Disease","volume":"49","author":"Staples","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2022.11.028_b0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.envres.2020.109114","article-title":"Reviewing estimates of the basic reproduction number for dengue, Zika and chikungunya across global climate zones","volume":"182","author":"Liu","year":"2020","journal-title":"Environ Res"},{"key":"10.1016\/j.vaccine.2022.11.028_b0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pntd.0006533","article-title":"Current challenges and implications for dengue, chikungunya and Zika seroprevalence studies worldwide: A scoping review","volume":"12","author":"Fritzell","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2022.11.028_b0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.tmaid.2020.101814","article-title":"Chikungunya resurgence in the Maldives and risk for importation via tourists to Europe in 2019\u20132020: A GeoSentinel case series","volume":"36","author":"Dudouet","year":"2020","journal-title":"Travel Med Infect Dis"},{"key":"10.1016\/j.vaccine.2022.11.028_b0220","doi-asserted-by":"crossref","first-page":"e0205058","DOI":"10.1371\/journal.pone.0205058","article-title":"Human and entomologic investigations of chikungunya outbreak in Mandera, Northeastern Kenya, 2016","volume":"13","author":"Konongoi","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2022.11.028_b0225","doi-asserted-by":"crossref","unstructured":"Laras K, Sukri NC, Larasati RP, Bangs MJ, Kosim R, Djauzi, et al. Tracking the re-emergence of epidemic chikungunya virus in Indonesia. Trans R Soc Trop Med Hyg 2005;99:128\u201341. https:\/\/doi.org\/10.1016\/j.trstmh.2004.03.013.","DOI":"10.1016\/j.trstmh.2004.03.013"},{"key":"10.1016\/j.vaccine.2022.11.028_b0230","doi-asserted-by":"crossref","first-page":"e0007978","DOI":"10.1371\/journal.pntd.0007978","article-title":"Impact of age-specific immunity on the timing and burden of the next Zika virus outbreak","volume":"13","author":"Counotte","year":"2019","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2022.11.028_b0235","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1093\/infdis\/jiy111","article-title":"Operationalizing International Regulatory Standards in a Limited-Resource Setting During an Epidemic: The Sierra Leone Trial to Introduce a Vaccine Against Ebola (STRIVE) Experience","volume":"217","author":"Kabineh","year":"2018","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2022.11.028_b0240","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1007\/s11538-012-9749-6","article-title":"A Note on the Derivation of Epidemic Final Sizes","volume":"74","author":"Miller","year":"2012","journal-title":"Bull Math Biol"},{"key":"10.1016\/j.vaccine.2022.11.028_b0245","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1098\/rsif.2011.0403","article-title":"Edge-based compartmental modelling for infectious disease spread","volume":"9","author":"Miller","year":"2012","journal-title":"J R Soc Interface"},{"key":"10.1016\/j.vaccine.2022.11.028_b0250","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1038\/s41467-019-09035-x","article-title":"Inter-annual variation in seasonal dengue epidemics driven by multiple interacting factors in Guangzhou","volume":"10","author":"Oidtman","year":"2019","journal-title":"China Nat Commun"},{"key":"10.1016\/j.vaccine.2022.11.028_b0255","article-title":"Epidemiological Evidence for Lineage-Specific Differences in the Risk of Inapparent Chikungunya Virus Infection","volume":"93","author":"Carrillo","year":"2019","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2022.11.028_b0260","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1016\/S2666-5247(20)30175-0","article-title":"Seroprevalence of chikungunya virus infection in India, 2017: a cross-sectional population-based serosurvey","volume":"2","author":"Kumar","year":"2021","journal-title":"Lancet Microbe"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22014268?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22014268?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:22:05Z","timestamp":1759404125000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X22014268"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S0264410X22014268"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.11.028","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2022.05.23.22275466","asserted-by":"object"}]},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expected endpoints from future chikungunya vaccine trial sites informed by serological data and modeling","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.11.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}